KoBioLabs, Inc (KOSDAQ:348150)

South Korea · Delayed Price · Currency is KRW

3,140.00

+60.00 (1.95%)

At close: Jul 21, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Health Functional Food Division			33.14B	11.61B	2.89B	4.59B	576.52M
Health Functional Food Division Growth			185.54%	301.12%	-36.98%	696.42%	798.53%
Total			33.14B	11.61B	2.89B	4.59B	576.52M
Total Growth			185.54%	301.12%	-36.98%	696.42%	798.53%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
South Korea			32.57B	10.67B	2.67B	4.59B	576.52M
South Korea Growth			205.23%	299.97%	-41.89%	696.42%	798.53%
Overseas			564.22M	933.81M	225.20M	-	-
Overseas Growth			-39.58%	314.67%	-	-	-
Total			33.14B	11.61B	2.89B	4.59B	576.52M
Total Growth			185.54%	301.12%	-36.98%	696.42%	798.53%